It offered a fresh perspective on the molecular role of HMGA‐2 and proposed a potential therapeutic use of DIC to stop the spread of colon cancer cells that overexpress HMGA‐2 (Chen et al. 2020). Here, HMGA2 is linked to malignant colon neoplasm.